Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moleculin Biotech (MBRX) Exchange Rate Effect (2018 - 2025)

Moleculin Biotech (MBRX) has 8 years of Exchange Rate Effect data on record, last reported at -$6000.0 in Q3 2025.

  • For Q3 2025, Exchange Rate Effect fell 142.86% year-over-year to -$6000.0; the TTM value through Sep 2025 reached -$48000.0, down 785.71%, while the annual FY2024 figure was -$32000.0, 52.38% down from the prior year.
  • Exchange Rate Effect reached -$6000.0 in Q3 2025 per MBRX's latest filing, down from $3000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $14000.0 in Q3 2024 and bottomed at -$45000.0 in Q4 2024.
  • Average Exchange Rate Effect over 5 years is -$6055.6, with a median of -$5000.0 recorded in 2021.
  • The widest YoY moves for Exchange Rate Effect: up 900.0% in 2024, down 650.0% in 2024.
  • A 5-year view of Exchange Rate Effect shows it stood at $2000.0 in 2021, then soared by 350.0% to $9000.0 in 2022, then tumbled by 166.67% to -$6000.0 in 2023, then tumbled by 650.0% to -$45000.0 in 2024, then skyrocketed by 86.67% to -$6000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were -$6000.0 in Q3 2025, $3000.0 in Q1 2025, and -$45000.0 in Q4 2024.